Literature DB >> 26792875

Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.

Yigal M Pinto1, Perry M Elliott2, Eloisa Arbustini3, Yehuda Adler4, Aris Anastasakis5, Michael Böhm6, Denis Duboc7, Juan Gimeno8, Pascal de Groote9, Massimo Imazio10, Stephane Heymans11, Karin Klingel12, Michel Komajda13, Giuseppe Limongelli14, Ales Linhart15, Jens Mogensen16, James Moon17, Petronella G Pieper18, Petar M Seferovic19, Stephan Schueler20, Jose L Zamorano21, Alida L P Caforio22, Philippe Charron23.   

Abstract

In this paper the Working Group on Myocardial and Pericardial Disease proposes a revised definition of dilated cardiomyopathy (DCM) in an attempt to bridge the gap between our recent understanding of the disease spectrum and its clinical presentation in relatives, which is key for early diagnosis and the institution of potential preventative measures. We also provide practical hints to identify subsets of the DCM syndrome where aetiology directed management has great clinical relevance. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Dilated cardiomyopathy; Heart failure; Position statement

Mesh:

Year:  2016        PMID: 26792875     DOI: 10.1093/eurheartj/ehv727

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  206 in total

Review 1.  Second Hits in Dilated Cardiomyopathy.

Authors:  Peter Marstrand; Kermshlise Picard; Neal K Lakdawala
Journal:  Curr Cardiol Rep       Date:  2020-01-24       Impact factor: 2.931

Review 2.  Management of survivors of cardiac arrest - the importance of genetic investigation.

Authors:  Peter J Schwartz; Federica Dagradi
Journal:  Nat Rev Cardiol       Date:  2016-07-07       Impact factor: 32.419

3.  Letter regarding the article "Immunomodulatory treatment for lymphocytic myocarditis-a systematic review and meta-analysis".

Authors:  Alexey Sarapultsev; Vasily Kashtalap; Petr Sarapultsev
Journal:  Heart Fail Rev       Date:  2021-01       Impact factor: 4.214

Review 4.  [Genetic testing to prevent sudden cardiac death].

Authors:  B Stallmeyer; S Dittmann; E Schulze-Bahr
Journal:  Internist (Berl)       Date:  2018-08       Impact factor: 0.743

5.  Shocks after implantable cardioverter-defibrillator implantation in idiopathic cardiomyopathy patients: a myocardial biopsy study.

Authors:  Erdal Safak; Giuseppe D Ancona; Heinz-Peter Schultheiss; Uwe Kühl; Stephan Kische; Hilmi Kaplan; Hüseyin Ince; Jasmin Ortak
Journal:  Heart Vessels       Date:  2017-08-14       Impact factor: 2.037

Review 6.  Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.

Authors:  Rui Guo; Sreejayan Nair
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-24       Impact factor: 5.187

Review 7.  Dilated Cardiomyopathy: Genetic Determinants and Mechanisms.

Authors:  Elizabeth M McNally; Luisa Mestroni
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

8.  Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study.

Authors:  Daniel D Kinnamon; Ana Morales; Deborah J Bowen; Wylie Burke; Ray E Hershberger
Journal:  Circ Cardiovasc Genet       Date:  2017-12

9.  Very long-term follow-up data of non-ischemic idiopathic dilated cardiomyopathy after beta-blocker therapy: recurrence of left ventricular dysfunction and predictive value of 123I-metaiodobenzylguanidine scintigraphy.

Authors:  Shunsuke Nishimura; Chisato Izumi; Yoshihiro Himura; Maiko Kuroda; Masashi Amano; Takeshi Harita; Suguru Nishiuchi; Jiro Sakamoto; Yodo Tamaki; Soichiro Enomoto; Makoto Miyake; Toshihiro Tamura; Hirokazu Kondo; Yoshihisa Nakagawa
Journal:  Heart Vessels       Date:  2018-08-24       Impact factor: 2.037

10.  Emerging Topics Update of the Brazilian Heart Failure Guideline - 2021.

Authors:  Fabiana G Marcondes-Braga; Lídia Ana Zytynski Moura; Victor Sarli Issa; Jefferson Luis Vieira; Luis Eduardo Rohde; Marcus Vinícius Simões; Miguel Morita Fernandes-Silva; Salvador Rassi; Silvia Marinho Martins Alves; Denilson Campos de Albuquerque; Dirceu Rodrigues de Almeida; Edimar Alcides Bocchi; Felix José Alvarez Ramires; Fernando Bacal; João Manoel Rossi Neto; Luiz Claudio Danzmann; Marcelo Westerlund Montera; Mucio Tavares de Oliveira Junior; Nadine Clausell; Odilson Marcos Silvestre; Reinaldo Bulgarelli Bestetti; Sabrina Bernadez-Pereira; Aguinaldo F Freitas; Andréia Biolo; Antonio Carlos Pereira Barretto; Antônio José Lagoeiro Jorge; Bruno Biselli; Carlos Eduardo Lucena Montenegro; Edval Gomes Dos Santos Júnior; Estêvão Lanna Figueiredo; Fábio Fernandes; Fabio Serra Silveira; Fernando Antibas Atik; Flávio de Souza Brito; Germano Emílio Conceição Souza; Gustavo Calado de Aguiar Ribeiro; Humberto Villacorta; João David de Souza Neto; Livia Adams Goldraich; Luís Beck-da-Silva; Manoel Fernandes Canesin; Marcelo Imbroinise Bittencourt; Marcely Gimenes Bonatto; Maria da Consolação Vieira Moreira; Mônica Samuel Avila; Otavio Rizzi Coelho Filho; Pedro Vellosa Schwartzmann; Ricardo Mourilhe-Rocha; Sandrigo Mangini; Silvia Moreira Ayub Ferreira; José Albuquerque de Figueiredo Neto; Evandro Tinoco Mesquita
Journal:  Arq Bras Cardiol       Date:  2021-06       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.